MSR109 Multi-Indication Evidence Synthesis in Oncology Health Technology Assessment: Case-Study on Bevacizumab

Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.2168
https://www.valueinhealthjournal.com/article/S1098-3015(23)05298-1/fulltext
Title : MSR109 Multi-Indication Evidence Synthesis in Oncology Health Technology Assessment: Case-Study on Bevacizumab
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)05298-1&doi=10.1016/j.jval.2023.09.2168
First page :
Section Title :
Open access? : No
Section Order : 11611
Categories :
Tags :
Regions :
ViH Article Tags :